Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss
2006-001984-53Phase 3Completed
- Sponsor
- Friedrich Schiller University Jena
- Start
- Jan 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of dalteparin in recurrent miscarriage (RPL), sponsored by Friedrich Schiller University Jena. Primary endpoint: ongoing intact pregnancy at 24 weeks of gestation. Started Jan 2007; status: completed.
02
Drugs
dalteparin
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on 2006-001984-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001984-53.